These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 22165685

  • 1. Bye-bye chiro-inositol - myo-inositol: true progress in the treatment of polycystic ovary syndrome and ovulation induction.
    Galletta M, Grasso S, Vaiarelli A, Roseff SJ.
    Eur Rev Med Pharmacol Sci; 2011 Oct; 15(10):1212-4. PubMed ID: 22165685
    [Abstract] [Full Text] [Related]

  • 2. The combined therapy with myo-inositol and D-chiro-inositol reduces the risk of metabolic disease in PCOS overweight patients compared to myo-inositol supplementation alone.
    Nordio M, Proietti E.
    Eur Rev Med Pharmacol Sci; 2012 May; 16(5):575-81. PubMed ID: 22774396
    [Abstract] [Full Text] [Related]

  • 3. Updates on the myo-inositol plus D-chiro-inositol combined therapy in polycystic ovary syndrome.
    Unfer V, Porcaro G.
    Expert Rev Clin Pharmacol; 2014 Sep; 7(5):623-31. PubMed ID: 24898153
    [Abstract] [Full Text] [Related]

  • 4. Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction.
    Papaleo E, Unfer V, Baillargeon JP, De Santis L, Fusi F, Brigante C, Marelli G, Cino I, Redaelli A, Ferrari A.
    Gynecol Endocrinol; 2007 Dec; 23(12):700-3. PubMed ID: 17952759
    [Abstract] [Full Text] [Related]

  • 5. The rationale of the myo-inositol and D-chiro-inositol combined treatment for polycystic ovary syndrome.
    Dinicola S, Chiu TT, Unfer V, Carlomagno G, Bizzarri M.
    J Clin Pharmacol; 2014 Oct; 54(10):1079-92. PubMed ID: 25042908
    [Abstract] [Full Text] [Related]

  • 6. Reflections on inositol(s) for PCOS therapy: steps toward success.
    Nestler JE, Unfer V.
    Gynecol Endocrinol; 2015 Jul; 31(7):501-5. PubMed ID: 26177098
    [Abstract] [Full Text] [Related]

  • 7. Inositol in Polycystic Ovary Syndrome: Restoring Fertility through a Pathophysiology-Based Approach.
    Laganà AS, Garzon S, Casarin J, Franchi M, Ghezzi F.
    Trends Endocrinol Metab; 2018 Nov; 29(11):768-780. PubMed ID: 30270194
    [Abstract] [Full Text] [Related]

  • 8. Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome.
    Nestler JE, Jakubowicz DJ, Reamer P, Gunn RD, Allan G.
    N Engl J Med; 1999 Apr 29; 340(17):1314-20. PubMed ID: 10219066
    [Abstract] [Full Text] [Related]

  • 9. [Evaluation of the treatment with D-chiro-inositol on levels of oxidative stress in PCOS patients].
    De Leo V, La Marca A, Cappelli V, Stendardi A, Focarelli R, Musacchio MC, Piomboni P.
    Minerva Ginecol; 2012 Dec 29; 64(6):531-8. PubMed ID: 23232537
    [Abstract] [Full Text] [Related]

  • 10. Role of inositolphosphoglycan mediators of insulin action in the polycystic ovary syndrome.
    Nestler JE, Jakubowicz DJ, Iuorno MJ.
    J Pediatr Endocrinol Metab; 2000 Dec 29; 13 Suppl 5():1295-8. PubMed ID: 11117673
    [Abstract] [Full Text] [Related]

  • 11. The Combined therapy myo-inositol plus D-Chiro-inositol, in a physiological ratio, reduces the cardiovascular risk by improving the lipid profile in PCOS patients.
    Minozzi M, Nordio M, Pajalich R.
    Eur Rev Med Pharmacol Sci; 2013 Feb 29; 17(4):537-40. PubMed ID: 23467955
    [Abstract] [Full Text] [Related]

  • 12. The combined therapy myo-inositol plus D-chiro-inositol, rather than D-chiro-inositol, is able to improve IVF outcomes: results from a randomized controlled trial.
    Colazingari S, Treglia M, Najjar R, Bevilacqua A.
    Arch Gynecol Obstet; 2013 Dec 29; 288(6):1405-11. PubMed ID: 23708322
    [Abstract] [Full Text] [Related]

  • 13. Combining treatment with myo-inositol and D-chiro-inositol (40:1) is effective in restoring ovary function and metabolic balance in PCOS patients.
    Monastra G, Unfer V, Harrath AH, Bizzarri M.
    Gynecol Endocrinol; 2017 Jan 29; 33(1):1-9. PubMed ID: 27898267
    [Abstract] [Full Text] [Related]

  • 14. Inositol: history of an effective therapy for Polycystic Ovary Syndrome.
    Bizzarri M, Carlomagno G.
    Eur Rev Med Pharmacol Sci; 2014 Jul 29; 18(13):1896-903. PubMed ID: 25010620
    [Abstract] [Full Text] [Related]

  • 15. Myo-inositol rather than D-chiro-inositol is able to improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.
    Unfer V, Carlomagno G, Rizzo P, Raffone E, Roseff S.
    Eur Rev Med Pharmacol Sci; 2011 Apr 29; 15(4):452-7. PubMed ID: 21608442
    [Abstract] [Full Text] [Related]

  • 16. The D-chiro-inositol paradox in the ovary.
    Carlomagno G, Unfer V, Roseff S.
    Fertil Steril; 2011 Jun 30; 95(8):2515-6. PubMed ID: 21641593
    [Abstract] [Full Text] [Related]

  • 17. The 40:1 myo-inositol/D-chiro-inositol plasma ratio is able to restore ovulation in PCOS patients: comparison with other ratios.
    Nordio M, Basciani S, Camajani E.
    Eur Rev Med Pharmacol Sci; 2019 Jun 30; 23(12):5512-5521. PubMed ID: 31298405
    [Abstract] [Full Text] [Related]

  • 18. Experts' opinion on inositols in treating polycystic ovary syndrome and non-insulin dependent diabetes mellitus: a further help for human reproduction and beyond.
    Facchinetti F, Appetecchia M, Aragona C, Bevilacqua A, Bezerra Espinola MS, Bizzarri M, D'Anna R, Dewailly D, Diamanti-Kandarakis E, Hernández Marín I, Kamenov ZA, Kandaraki E, Laganà AS, Monastra G, Montanino Oliva M, Nestler JE, Orio F, Ozay AC, Papalou O, Pkhaladze L, Porcaro G, Prapas N, Soulage CO, Stringaro A, Wdowiak A, Unfer V.
    Expert Opin Drug Metab Toxicol; 2020 Mar 30; 16(3):255-274. PubMed ID: 32129111
    [Abstract] [Full Text] [Related]

  • 19. D-Chiro-inositol and its significance in polycystic ovary syndrome: a systematic review.
    Galazis N, Galazi M, Atiomo W.
    Gynecol Endocrinol; 2011 Apr 30; 27(4):256-62. PubMed ID: 21142777
    [Abstract] [Full Text] [Related]

  • 20. Results from the International Consensus Conference on Myo-inositol and d-chiro-inositol in Obstetrics and Gynecology: the link between metabolic syndrome and PCOS.
    Facchinetti F, Bizzarri M, Benvenga S, D'Anna R, Lanzone A, Soulage C, Di Renzo GC, Hod M, Cavalli P, Chiu TT, Kamenov ZA, Bevilacqua A, Carlomagno G, Gerli S, Oliva MM, Devroey P.
    Eur J Obstet Gynecol Reprod Biol; 2015 Dec 30; 195():72-76. PubMed ID: 26479434
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.